A detailed history of Jacobs Levy Equity Management, Inc transactions in Personalis, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 405,670 shares of PSNL stock, worth $2.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
405,670
Previous 735,005 44.81%
Holding current value
$2.41 Million
Previous $859,000 154.02%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.19 - $6.34 $391,908 - $2.09 Million
-329,335 Reduced 44.81%
405,670 $2.18 Million
Q2 2024

Aug 14, 2024

SELL
$1.17 - $1.65 $101,382 - $142,975
-86,652 Reduced 10.55%
735,005 $859,000
Q1 2024

May 15, 2024

BUY
$1.15 - $2.19 $558,695 - $1.06 Million
485,822 Added 144.66%
821,657 $1.22 Million
Q4 2023

Feb 14, 2024

SELL
$0.93 - $2.35 $101,433 - $256,309
-109,068 Reduced 24.52%
335,835 $705,000
Q3 2023

Nov 16, 2023

SELL
$1.19 - $2.36 $74,563 - $147,872
-62,658 Reduced 12.34%
444,903 $538,000
Q2 2023

Aug 14, 2023

BUY
$1.8 - $3.19 $389,593 - $690,446
216,441 Added 74.35%
507,561 $954,000
Q1 2023

May 15, 2023

BUY
$2.01 - $4.17 $180,688 - $374,862
89,895 Added 44.67%
291,120 $803,000
Q4 2022

Feb 14, 2023

SELL
$1.78 - $3.64 $133,193 - $272,373
-74,828 Reduced 27.11%
201,225 $398,000
Q3 2022

Nov 15, 2022

SELL
$2.89 - $5.32 $1.53 Million - $2.81 Million
-528,568 Reduced 65.69%
276,053 $820,000
Q2 2022

Aug 15, 2022

BUY
$3.27 - $8.76 $2.48 Million - $6.64 Million
757,559 Added 1609.7%
804,621 $2.78 Million
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $355,788 - $672,986
47,062 New
47,062 $385,000
Q3 2020

Nov 16, 2020

SELL
$13.63 - $24.12 $201,015 - $355,721
-14,748 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$7.65 - $14.11 $112,822 - $208,094
14,748 New
14,748 $191,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $273M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.